Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00178854
Status:
WITHDRAWN
Last Update Posted:
2017-04-04
First Post:
2005-09-12
Brief Title:
Risperidone Risperdal Augmentation in Depressed Partial Responders to SRI Treatment
Sponsor:
Vanderbilt University Medical Center
Organization:
Vanderbilt University Medical Center
Study Overview
Official Title:
Risperidone Risperdal Augmentation in Depressed Partial Responders to SRI Treatment
Status:
WITHDRAWN
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
failed recruitment efforts
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a study of the chemistry of depression in people who are taking an antidepressant but it is not working well The changes in brain chemicals that occur when an SSRI type antidepressant is supplemented with risperidone Risperdal will be studied Spinal fluid is used to measure chemical levels of dopamine serotonin and other chemicals thought to be involved in depression The study has potential to help understand and treat depression
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RIS-USA-T31 | None | None | None |
| RIS-BIP-404 | None | None | None |
| VUMC30141-R | None | None | None |